Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2019
Historique:
received: 05 03 2019
accepted: 27 06 2019
revised: 08 08 2019
pubmed: 30 7 2019
medline: 3 1 2020
entrez: 30 7 2019
Statut: epublish

Résumé

Metabolically quiescent pathogens can persist in a viable non-replicating state for months or even years. For certain infectious diseases, such as tuberculosis, cryptococcosis, histoplasmosis, latent infection is a corollary of this dormant state, which has the risk for reactivation and clinical disease. During murine cryptococcosis and macrophage uptake, stress and host immunity induce Cryptococcus neoformans heterogeneity with the generation of a sub-population of yeasts that manifests a phenotype compatible with dormancy (low stress response, latency of growth). In this subpopulation, mitochondrial transcriptional activity is regulated and this phenotype has been considered as a hallmark of quiescence in stem cells. Based on these findings, we worked to reproduce this phenotype in vitro and then standardize the experimental conditions to consistently generate this dormancy in C. neoformans. We found that incubation of stationary phase yeasts (STAT) in nutriment limited conditions and hypoxia for 8 days (8D-HYPOx) was able to produced cells that mimic the phenotype obtained in vivo. In these conditions, mortality and/or apoptosis occurred in less than 5% of the yeasts compared to 30-40% of apoptotic or dead yeasts upon incubation in normoxia (8D-NORMOx). Yeasts in 8D-HYPOx harbored a lower stress response, delayed growth and less that 1% of culturability on agar plates, suggesting that these yeasts are viable but non culturable cells (VBNC). These VBNC were able to reactivate in the presence of pantothenic acid, a vitamin that is known to be involved in quorum sensing and a precursor of acetyl-CoA. Global metabolism of 8D-HYPOx cells showed some specific requirements and was globally shut down compared to 8D-NORMOx and STAT conditions. Mitochondrial analyses showed that the mitochondrial mass increased with mitochondria mostly depolarized in 8D-HYPOx compared to 8D-NORMox, with increased expression of mitochondrial genes. Proteomic and transcriptomic analyses of 8D-HYPOx revealed that the number of secreted proteins and transcripts detected also decreased compared to 8D-NORMOx and STAT, and the proteome, secretome and transcriptome harbored specific profiles that are engaged as soon as four days of incubation. Importantly, acetyl-CoA and the fatty acid pathway involving mitochondria are required for the generation and viability maintenance of VBNC. Altogether, these data show that we were able to generate for the first time VBNC phenotype in C. neoformans. This VBNC state is associated with a specific metabolism that should be further studied to understand dormancy/quiescence in this yeast.

Identifiants

pubmed: 31356623
doi: 10.1371/journal.ppat.1007945
pii: PPATHOGENS-D-19-00432
pmc: PMC6687208
doi:

Substances chimiques

Culture Media 0
Fatty Acids 0
Fungal Proteins 0
Pantothenic Acid 19F5HK2737
Oxygen S88TT14065

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007945

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI073896
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI093257
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059842
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI033142
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI033774
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI052733
Pays : United States

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Bacteriol. 1994 Sep;176(18):5802-13
pubmed: 8083172
Appl Environ Microbiol. 1997 May;63(5):2047-53
pubmed: 9143134
Eukaryot Cell. 2012 May;11(5):560-70
pubmed: 22447924
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15245-50
pubmed: 11742090
Clin Proteomics. 2014 Feb 03;11(1):5
pubmed: 24484775
Environ Microbiol. 2007 May;9(5):1267-77
pubmed: 17472639
Am J Clin Pathol. 1954 Dec;24(12):1381-90
pubmed: 13228372
Am J Clin Pathol. 1976 Jan;65(1):83-92
pubmed: 1246992
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
J Fungi (Basel). 2018 Mar 20;4(1):
pubmed: 30152809
PLoS One. 2016 Apr 07;11(4):e0153356
pubmed: 27054608
BMC Microbiol. 2015 Oct 09;15:206
pubmed: 26453029
Cell Stem Cell. 2014 May 1;14(5):592-605
pubmed: 24656769
Bioessays. 2003 Mar;25(3):204-11
pubmed: 12596224
Infect Immun. 2005 Aug;73(8):4922-33
pubmed: 16041006
Mol Biosyst. 2015 Sep;11(9):2529-40
pubmed: 26181685
J Med Vet Mycol. 1992;30(5):395-7
pubmed: 1469541
Nat Commun. 2012 Jun 12;3:903
pubmed: 22692546
J Microbiol. 2004 Jun;42(2):69-73
pubmed: 15357297
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Mycopathologia. 2012 Jun;173(5-6):407-18
pubmed: 21898146
Biochem Soc Trans. 2014 Aug;42(4):1112-7
pubmed: 25110011
BMC Bioinformatics. 2014 Aug 29;15:293
pubmed: 25176396
Eukaryot Cell. 2004 Oct;3(5):1076-87
pubmed: 15470236
J Antimicrob Chemother. 2013 Aug;68(8):1801-11
pubmed: 23612570
Int J Biochem Cell Biol. 2006;38(9):1476-81
pubmed: 16647875
Genome Biol. 2014;15(12):550
pubmed: 25516281
Int J Food Microbiol. 2000 Apr 10;55(1-3):285-90
pubmed: 10791759
FEMS Microbiol Ecol. 2007 Oct;62(1):1-11
pubmed: 17908096
Parasitology. 2018 Nov;145(13):1765-1771
pubmed: 29564998
Am J Pathol. 2003 Aug;163(2):663-71
pubmed: 12875985
FEMS Microbiol Rev. 2010 Jul;34(4):415-25
pubmed: 20059548
Mol Cell. 2017 Sep 21;67(6):936-946.e5
pubmed: 28918901
Biochem J. 2012 Jan 15;441(2):523-40
pubmed: 22187934
Nat Rev Microbiol. 2005 Oct;3(10):753-64
pubmed: 16132036
mBio. 2014 Jun 17;5(3):e00945-14
pubmed: 24939886
Eukaryot Cell. 2012 Aug;11(8):1042-54
pubmed: 22707485
Semin Immunopathol. 2016 Mar;38(2):139-52
pubmed: 26490974
Eukaryot Cell. 2009 Dec;8(12):1901-8
pubmed: 19820119
Infect Immun. 1994 Nov;62(11):4755-61
pubmed: 7927751
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Microbiology. 2010 Jan;156(Pt 1):81-7
pubmed: 19797356
PLoS Genet. 2015 Aug 27;11(8):e1005490
pubmed: 26313153
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
PLoS One. 2018 Sep 20;13(9):e0198384
pubmed: 30235203
J Infect. 2018 Dec;77(6):463-468
pubmed: 30417827
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Microbiome. 2017 Aug 16;5(1):86
pubmed: 28810907
Crit Rev Microbiol. 2015 Feb;41(1):61-76
pubmed: 23848175
mBio. 2011 Aug 09;2(4):
pubmed: 21828220
Microbiol Rev. 1987 Sep;51(3):365-79
pubmed: 3312987
Infect Immun. 1996 Jun;64(6):2062-9
pubmed: 8675308
Food Microbiol. 2012 Jun;30(2):438-47
pubmed: 22365358
PLoS Pathog. 2018 May 18;14(5):e1006982
pubmed: 29775480
Science. 2014 Jan 10;343(6167):204-8
pubmed: 24408438
J Bacteriol. 1985 Jan;161(1):385-92
pubmed: 3881394
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Front Microbiol. 2014 Jun 02;5:258
pubmed: 24917854
Eukaryot Cell. 2008 Jan;7(1):58-67
pubmed: 18039940
Circulation. 2004 Apr 6;109(13):1660-7
pubmed: 15023888
mBio. 2014 Sep 16;5(5):e01649-14
pubmed: 25227465
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Nature. 1996 Jan 4;379(6560):88-91
pubmed: 8538748
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Microbiology. 2009 Dec;155(Pt 12):3860-3867
pubmed: 19729402
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
FEMS Microbiol Rev. 2012 Mar;36(2):306-39
pubmed: 21658086
Nat Biotechnol. 2014 Aug;32(8):795-803
pubmed: 25093887
Front Cell Infect Microbiol. 2016 Feb 15;6:6
pubmed: 26913242
Blood. 2003 Dec 15;102(13):4336-44
pubmed: 12881314
Med Mycol. 2016 Jan;54(1):40-58
pubmed: 26483436
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Cytometry A. 2003 Jan;51(1):16-25
pubmed: 12500301
Nucleic Acids Res. 2017 Jan 4;45(D1):D200-D203
pubmed: 27899674
Yeast. 1994 Feb;10(2):151-7
pubmed: 8203157
PLoS One. 2013 Oct 29;8(10):e77600
pubmed: 24204887
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
J Clin Microbiol. 1999 Oct;37(10):3204-9
pubmed: 10488178
Cell Host Microbe. 2013 Jun 12;13(6):643-51
pubmed: 23768489
Genome Res. 2001 Jul;11(7):1246-55
pubmed: 11435407
PLoS Pathog. 2011 Nov;7(11):e1002364
pubmed: 22114551
Infect Immun. 1994 Sep;62(9):3864-72
pubmed: 8063403
mBio. 2013 Dec 31;5(1):e00986-13
pubmed: 24381301
J Appl Microbiol. 2005;99(1):85-93
pubmed: 15960668
Cell Host Microbe. 2016 Jun 8;19(6):849-64
pubmed: 27212659
Yeast. 1998 Dec;14(16):1511-27
pubmed: 9885153
Eukaryot Cell. 2013 May;12(5):761-74
pubmed: 23524994
Am J Clin Pathol. 1955 Jan;25(1):14-24
pubmed: 14349908
J Gen Microbiol. 1972 Apr;70(1):115-22
pubmed: 4339338
J Biol Chem. 2001 Mar 30;276(13):9583-6
pubmed: 11266435
Adv Microb Physiol. 2003;47:65-129
pubmed: 14560663
Mol Microbiol. 2008 Sep;69(6):1456-75
pubmed: 18673460
Biosci Biotechnol Biochem. 2012;76(6):1085-90
pubmed: 22790927
Bioinformatics. 2015 Feb 1;31(3):445-6
pubmed: 25294921
J Biol Chem. 2003 May 2;278(18):16414-22
pubmed: 12601005
Nat Protoc. 2014 Feb;9(2):362-74
pubmed: 24434803
Nucleic Acids Res. 2004 Feb 20;32(3):e34
pubmed: 14978222
Biochem Soc Trans. 2014 Aug;42(4):1075-9
pubmed: 25110005
Science. 1997 Oct 24;278(5338):680-6
pubmed: 9381177
Infect Immun. 2015 Nov;83(11):4194-203
pubmed: 26283335
Methods Mol Biol. 2017;1611:59-73
pubmed: 28451972
PLoS One. 2009 Jul 29;4(7):e6413
pubmed: 19641610
mBio. 2015 Mar 31;6(2):
pubmed: 25827423
Mol Microbiol. 2007 May;64(3):591-601
pubmed: 17462010
Eukaryot Cell. 2008 Dec;7(12):2069-77
pubmed: 18820075

Auteurs

Benjamin Hommel (B)

Institut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Groupe Hospitalier Lariboisière, Saint-Louis, Fernand Widal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Aude Sturny-Leclère (A)

Institut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.

Stevenn Volant (S)

Institut Pasteur - Bioinformatics and Biostatistics Hub - C3BI, USR 3756 IP CNRS, Paris, France.

Nathanaël Veluppillai (N)

Institut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.

Magalie Duchateau (M)

Institut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.

Chen-Hsin Yu (CH)

Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.

Véronique Hourdel (V)

Institut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.

Hugo Varet (H)

Institut Pasteur - Bioinformatics and Biostatistics Hub - C3BI, USR 3756 IP CNRS, Paris, France.
Institut Pasteur - Transcriptome and Epigenome Platform - Biomics Pole - C2RT, Paris, France.

Mariette Matondo (M)

Institut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.

John R Perfect (JR)

Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.

Arturo Casadevall (A)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Françoise Dromer (F)

Institut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.

Alexandre Alanio (A)

Institut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Groupe Hospitalier Lariboisière, Saint-Louis, Fernand Widal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH